Empowered Patient Podcast

Nassim Usman, CEO, Catalyst Biosciences discusses the problem of Hemophilia, a rare and debilitating disease in which patients have a genetic deficiency in their ability to prevent bleeding. Currently, these patients must receive cumbersome bi-weekly IV infusions of clotting factor replacement therapy and may still bleed. Catalyst is developing a solution to give these patients a better and more convenient treatment particularly for inhibitor patients who have developed antibodies to their replacement therapy.

@catalystbio

#hemophilia #catalystbio #subQ #biotech

Catalyst Biosciences

Listen to the podcast here.

Nassim Usman, CEO, Catalyst Biosciences discusses the problem of Hemophilia, a rare disease in which patients have a genetic deficiency in their ability to prevent bleeding. Currently, these patients must receive cumbersome bi-weekly IV infusions of clotting factor replacement therapy and may still bleed. Catalyst is developing a solution to give these patients a better and more convenient treatment particularly for inhibitor patients who have developed antibodies to their replacement therapy.

@catalystbio

#hemophilia #catalystbio #subQ #biotech

Catalyst Biosciences

Download the transcript here.

Sam Liu, Vice President Marketing, VivaLNK talks about the current state of health wearables and how they are powering the growth of remote patient monitoring (RPM), how continuous monitoring changes the relationship between doctors and patients, and advances in sensors which will make it easier for patients to comply with reporting and treatment plans.

@viva_LNK

VivaLNK.com

Listen to the podcast here.

Sam Liu, Vice President Marketing, VivaLNK talks about the current state of health wearables and how they are powering the growth of remote patient monitoring (RPM), how continuous monitoring changes the relationship between doctors and patients, and advances in sensors which will make it easier for patients to comply with reporting and treatment plans.

@viva_LNK

VivaLNK.com

Download the transcript here.

Chris Hutchison, CEO, Cheetah Medical discusses the importance of a non-invasive, easy to use way to assess if a patient will respond positively to IV fluids in emergencies and in other critical care situations, and how Cheetah Medical devices are empowering healthcare providers by providing real time, continuous information to allow them to dose fluids safely, dynamically and with confidence they are doing no harm.

@Cheetah_Medical

#IVFluid #FluidManagement #sepsis #criticalcare

Cheetah Medical

Listen to the podcast here.

Chris Hutchison, CEO, Cheetah Medical discusses the importance of a non-invasive, easy to use way to assess if a patient will respond positively to IV fluids in emergencies and in other critical care situations, and how Cheetah Medical devices are empowering healthcare providers by providing real time, continuous information to allow them to dose fluids safely, dynamically and with confidence they are doing no harm.

@Cheetah_Medical

#IVFluid #FluidManagement #sepsis #criticalcare

Cheetah Medical

Download the transcript here.

Alexis Peyroles, CEO, OSE Immunotherapeutics talks about the important role the immune system plays in the development of a number of diseases. OSE is a biotechnology company focused on the therapies that control the immune system for treatment of cancers and autoimmune diseases. We discuss how drugs that regulate the immune system can provide the basis for the next generation of oncology and autoimmune disease treatments.

@OSEImmuno

#autoimmune #ImmunoOncology #Oncology #OSE_IMMUNO

OSE Immunotherapeutics

Listen to the podcast here

Alexis Peyroles, CEO, OSE Immunotherapeutics talks about the important role the immune system plays in the development of a number of diseases. OSE is a biotechnology company focused on the therapies that control the immune system for treatment of cancers and autoimmune diseases. We discuss how drugs that regulate the immune system can provide the basis for the next generation of oncology and autoimmune disease treatments.

@OSEImmuno

#autoimmune #ImmunoOncology #Oncology #OSE_IMMUNO

OSE Immunotherapeutics

Download the transcript here

Dr. Tony Fiorino, Chief Medical Officer, electroCore discusses the challenge of managing and preventing primary and secondary headaches particularly migraines, the science behind the electroCore non-invasive vagus nerve stimulator gammaCore(TM) and understanding the neurological triggers and mechanisms of headache disorders.

@electroCoreVNS

#migraine #headaches #neuromodulation #non-invasive #vagusnervestimulation #neurology

electroCore.com

Listen to the podcast here.

Dr. Tony Fiorino, Chief Medical Officer, electroCore discusses the challenge of managing and preventing primary and secondary headaches particularly migraines, the science behind the electroCore non-invasive vagus nerve stimulator gammaCore(TM) and understanding the neurological triggers and mechanisms of headache disorders.

@electroCoreVNS

#migraine #headaches #neuromodulation #non-invasive #vagusnervestimulation #neurology

electroCore.com

Download the transcript here.